Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Joey Two-Cents who wrote (8562)	5/8/1998 6:10:00 AM
From: Alexander Pavlov	Respond to of 18691

<< The difference between a KTEL and ENMD is that KTEL comes out with a hype story every day and justifies its price. ENMD does no such thing and is actually working against the mania. ... Anyway I bought the June 35 puts on ENMD because I wanted the daytraders to have their fun and move on to something new in a couple of weeks and let this one seek its own level by strike date.>> Any hype about ENMD could rise serious ethical issues. But look at this, nice job, just "consider the money Children's Hospital can make out of ENMD's drug": from yesterday's wsj.com (I believe hardcopy issue also contains this) --------------------------- Children's Hospital of Boston Stands To Gain if Cancer Drug Gets to Market By JON G. AUERBACH Staff Reporter of THE WALL STREET JOURNAL .. The hospital has already received $9 million in research money from EntreMed Inc., the Rockville, Md., biotechnology company that is working to develop two new cancer drugs based on the discoveries. .. But the real windfall would come from royalty payments and other considerations if EntreMed brings a drug to market. The royalties are somewhere in the range of 5% of drug sales, which could translate into $50 million a year or more if any EntreMed cancer drug reaches the blockbuster status of nostrums such as the antidepressant Prozac. ------------------------------- I think yesterday's ENMD move was in part dead cat's bounce and in part because of the publications like that. Anyway, getting overparanoid due to recent market developments I had to pay extra premium for November puts :o) Good luck to everybody, Alex